Transforming
Medicine Through
Transforming
Medicine Through
iPSC Innovation
iPSC Innovation
Pioneering breakthrough therapies that transform lives and redefine what's possible in modern medicine
Why Choose LumiSTAR?
Why We Excel
Our comprehensive technology platform positions us at the forefront of regenerative
Our comprehensive technology platform positions us at the forefront of regenerative medicine, delivering solutions that bridge the gap between cutting-edge research and clinical applications. LumiSTAR stands apart through integrating our three unique capabilities:
iPSC Excellence
Our iPSC technology enables us to develop various differentiated cell types and create patient-specific disease models for both drug discovery and therapeutics.
iPSC Excellence
Our iPSC technology enables us to develop various differentiated cell types and create patient-specific disease models for both drug discovery and therapeutics.
iPSC Excellence
Our iPSC technology enables us to develop various differentiated cell types and create patient-specific disease models for both drug discovery and therapeutics.
Delivery Efficiency
Our sophisticated viral delivery platform enables the installation of genetically encoded tools inside cells for labeling, measurement, and therapeutic purposes.
Imaging Expertise
Our genetically encoded, protein-based fluorescent probes offer low-toxicity, real-time cellular activity monitoring with customizable targeting.
iPSC Excellence
Our iPSC technology enables us to develop various differentiated cell types and create patient-specific disease models for both drug discovery and therapeutics.
iPSC Excellence
Our iPSC technology enables us to develop various differentiated cell types and create patient-specific disease models for both drug discovery and therapeutics.
iPSC Excellence
Our iPSC technology enables us to develop various differentiated cell types and create patient-specific disease models for both drug discovery and therapeutics.
Delivery Efficiency
Our sophisticated viral delivery platform enables the installation of genetically encoded tools inside cells for labeling, measurement, and therapeutic purposes.
Imaging Expertise
Our genetically encoded, protein-based fluorescent probes offer low-toxicity, real-time cellular activity monitoring with customizable targeting.
Why Choose LumiSTAR?
Why We Excel
Our comprehensive technology platform positions us at the forefront of regenerative medicine, delivering solutions that bridge the gap between cutting-edge research and clinical applications. LumiSTAR stands apart through integrating our three unique capabilities:
iPSC Excellence
Our iPSC technology enables us to develop various differentiated cell types and create patient-specific disease models for both drug discovery and therapeutics.
iPSC Excellence
Our iPSC technology enables us to develop various differentiated cell types and create patient-specific disease models for both drug discovery and therapeutics.
iPSC Excellence
Our iPSC technology enables us to develop various differentiated cell types and create patient-specific disease models for both drug discovery and therapeutics.
Delivery Efficiency
Our sophisticated viral delivery platform enables the installation of genetically encoded tools inside cells for labeling, measurement, and therapeutic purposes.
Imaging Expertise
Our genetically encoded, protein-based fluorescent probes offer low-toxicity, real-time cellular activity monitoring with customizable targeting.
Focus Areas
Focus Areas
Innovating for
unmet medical needs
Innovating for
unmet medical needs
We target critical unmet medical needs with innovative therapeutic approaches
We target critical unmet medical needs with innovative therapeutic approaches
Neurodegenerative Diseases
Neurodegenerative Diseases
LumiSTAR’s iPSC-derived neural models provide revolutionary approaches to understanding and treating neurodegenerative conditions, such as Parkinson's and Alzheimer's Disease.
LumiSTAR’s iPSC-derived neural models provide revolutionary approaches to understanding and treating neurodegenerative conditions, such as Parkinson's and Alzheimer's Disease.
Patient-specific disease modeling for drug screening
Development of neuroprotective therapies
Real-time monitoring of neuronal function and dynamics
Patient-specific disease modeling for drug screening
Development of neuroprotective therapies
Real-time monitoring of neuronal function and dynamics
Cardiovascular Diseases
Cardiovascular Diseases
LumiSTAR’s platform is ideal for preclinical cardiotoxicity and neurotoxicity evaluation, addressing the leading causes of drug attrition in pharmaceutical development.
LumiSTAR’s platform is ideal for preclinical cardiotoxicity and neurotoxicity evaluation, addressing the leading causes of drug attrition in pharmaceutical development.
Human-relevant models that better predict clinical toxicity
Real-time monitoring of function using our LumiRDT technology
Personalized toxicity assessment using patient-specific iPSC lines
Human-relevant models that better predict clinical toxicity
Real-time monitoring of function using our LumiRDT technology
Personalized toxicity assessment using patient-specific iPSC lines
Chronic Kidney Diseases
Chronic Kidney Diseases
LumiSTAR offers kidney organoids and disease models for therapeutic development and regenerative applications, addressing CKD that affects millions worldwide.
LumiSTAR offers kidney organoids and disease models for therapeutic development and regenerative applications, addressing CKD that affects millions worldwide.
Modeling kidney fibrosis in vitro for drug screening
Development of regenerative therapy that helps ameliorate kidney damage and fibrosis
Modeling kidney fibrosis in vitro for drug screening
Development of regenerative therapy that helps ameliorate kidney damage and fibrosis
About LumiSTAR
Making the incurable curable
Making the incurable curable
Making the incurable curable
About LumiSTAR
News
News
Stay Updated With
Our Breakthroughs, Events,
and Partnerships
Stay Updated With Our Breakthroughs, Events, and Partnerships
LumiSTAR and Aivita Health Group Launch Joint Venture
LumiSTAR and Aivita Health Group Launch Joint Venture to Tackle the Global Regenerative Medicine Market
LumiSTAR and Aivita Health Group Launch Joint Venture
LumiSTAR and Aivita Health Group Launch Joint Venture to Tackle the Global Regenerative Medicine Market
2025 Healthcare+ Expo, Taiwan
LumiSTAR Biotech and Its Automation Manufacturing Partners Showcase at Healthcare+ Expo Taiwan 2025
2025 Healthcare+ Expo, Taiwan
LumiSTAR Biotech and Its Automation Manufacturing Partners Showcase at Healthcare+ Expo Taiwan 2025
2025 Regenerative Medicine Summit: Pioneering Cell Therapy
LumiSTAR Leads Cross-National Experts on Stage — Unpacking iPSC Drug Screening Platforms, Clinical Translation, and Key Manufacturing Challenges
2025 Regenerative Medicine Summit: Pioneering Cell Therapy
LumiSTAR Leads Cross-National Experts on Stage — Unpacking iPSC Drug Screening Platforms, Clinical Translation, and Key Manufacturing Challenges
LumiSTAR and Aivita Wellness Clinic Launch Regenerative Medicine Collaboration in Dubai
Building a Smart Cell Therapy Hub in the Middle East
LumiSTAR and Aivita Wellness Clinic Launch Regenerative Medicine Collaboration in Dubai
Building a Smart Cell Therapy Hub in the Middle East
LumiSTAR and Aivita Health Group Launch Joint Venture
LumiSTAR and Aivita Health Group Launch Joint Venture to Tackle the Global Regenerative Medicine Market
2025 Regenerative Medicine Summit: Pioneering Cell Therapy
LumiSTAR Leads Cross-National Experts on Stage — Unpacking iPSC Drug Screening Platforms, Clinical Translation, and Key Manufacturing Challenges
2025 Healthcare+ Expo, Taiwan
LumiSTAR Biotech and Its Automation Manufacturing Partners Showcase at Healthcare+ Expo Taiwan 2025
Get in touch
Explore Support and Partnerships
Get in touch
Explore Support and Partnerships
Get in touch
Explore Support and Partnerships
Copyright © 2025 LumiSTAR Biotechnology, Inc. All Rights Reserved
Privacy Policy | Terms & Conditions
Copyright © 2025 LumiSTAR Biotechnology, Inc. All Rights Reserved
Privacy Policy | Terms & Conditions
Copyright © 2025 LumiSTAR Biotechnology, Inc. All Rights Reserved
Privacy Policy | Terms & Conditions